LY6E Antikörper (AA 21-101) (HRP)
Kurzübersicht für LY6E Antikörper (AA 21-101) (HRP) (ABIN8006806)
Target
Alle LY6E Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 21-101
-
Verwendungszweck
- Anti-LY6E/SCA-2 Antibody HRP Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human LY6E/SCA-2 recombinant protein (Position: L21-S101).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- LY6E (Lymphocyte Antigen 6 Complex, Locus E (LY6E))
-
Andere Bezeichnung
- LY6E
-
Hintergrund
-
Background: Lymphocyte antigen 6E is a protein that in humans is encoded by the LY6E gene. Increased expression of Ly6E is associated with poor survival outcome in multiple malignancies as determined by a survey of more than 130 published clinical studies of gene expression studies on cancer tissue samples and adjacent normal tissues. Ly6E is associated with drug resistance and tumor immune escape in breast cancer. Further research is required to validate Ly6E for translation research.
Gene Full Name: lymphocyte antigen 6 family member E
-
Gen-ID
- 4061
-
UniProt
- Q16553
-
Pathways
- Hormone Transport
Target
-